MiR-142-3p functions as an oncogene in prostate cancer by targeting FOXO1
Yi-Fan Tan, Zhiyuan Chen, Lei Wang, Min Wang, Xiuheng Liu · Journal of Cancer · 2020
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2020
Abstract
Prostate cancer (PCa) is a heterogeneous malignancy, and is a primary cause of cancer-related death in males.Forkhead box transcription factor O1 (FOXO1) exerts antitumor effects in various cancers, including PCa.However, the regulatory mechanism of miR-142-3p on FOXO1 expression in human PCa has not been characterized.In this study, we showed that FOXO1 protein levels were downregulated in PCa tissues and cells.Moreover, FOXO1 expression was a predictor of disease-free survival in patients with PCa and was a predictor of prognosis.Increased expression of FOXO1 suppressed cellular proliferation and induced cell cycle arrest at G0/G1 in vitro.However, FOXO1 mRNA and protein levels were inconsistent in human PCa tissues and cell lines.We showed that miR-142-3p levels were negatively correlated with FOXO1 protein levels in PCa.We also showed that miR-142-3p suppressed FOXO1 expression by directly targeting its 3′-untranslated region.Furthermore, suppression of miR-142-3p inhibited cell proliferation and induced cell cycle arrest, and these effects were blocked by FOXO1 knockdown.In vivo experiments showed that miR-142-3p knockout impaired tumor growth.Our results validate that FOXO1 acted as a tumor suppressor in PCa and demonstrated that FOXO1 was regulated by miR-142-3p, and miR-142-3p may be a potential target for treatment of PCa.
Open the resolved locator · 10.7150/jca.41888
Metadata licence: OpenAlex metadata (CC0)